Literature DB >> 29959962

Onychomycosis: Treatment and prevention of recurrence.

Shari R Lipner1, Richard K Scher2.   

Abstract

Onychomycosis is a fungal nail infection caused by dermatophytes, nondermatophytes, and yeast, and is the most common nail disorder seen in clinical practice. It is an important problem because it may cause local pain, paresthesias, difficulties performing activities of daily living, and impair social interactions. The epidemiology, risk factors, and clinical presentation and diagnosis of onychomycosis were discussed in the first article in this continuing medical education series. In this article, we review the prognosis and response to onychomycosis treatment, medications for onychomycosis that have been approved by the US Food and Drug Administration, and off-label therapies and devices. Methods to prevent onychomycosis recurrences and emerging therapies are also described.
Copyright © 2018 American Academy of Dermatology, Inc. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  booster therapy; ciclopirox; clinical cure; complete cure; efinaconazole; fluconazole; fungal nail infection; itraconazole; lasers; mycologic cure; onychomycosis; photodynamic therapy; plasma therapy; pulse dosing; tavaborole; terbinafine; treatment

Mesh:

Substances:

Year:  2018        PMID: 29959962     DOI: 10.1016/j.jaad.2018.05.1260

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN: 0190-9622            Impact factor:   11.527


  37 in total

1.  Outpatient Antifungal Prescribing Patterns in the United States, 2018.

Authors:  Kaitlin Benedict; Sharon V Tsay; Monina G Bartoces; Snigdha Vallabhaneni; Brendan R Jackson; Lauri A Hicks
Journal:  Antimicrob Steward Healthc Epidemiol       Date:  2022-12-22

Review 2.  Dermoscopic Evaluation of Inflammatory Nail Disorders and Their Mimics.

Authors:  Sophie Soyeon Lim; Alex Chamberlain; Keunyoung Hur; Jungyoon Ohn; Byeol Han; Victoria Mar; Je-Ho Mun
Journal:  Acta Derm Venereol       Date:  2021-09-15       Impact factor: 3.875

3.  A Deep Learning Approach for Histopathological Diagnosis of Onychomycosis: Not Inferior to Analogue Diagnosis by Histopathologists.

Authors:  Florence Decroos; Sebastian Springenberg; Tobias Lang; Marc Päpper; Antonia Zapf; Dieter Metze; Volker Steinkraus; Almut Böer-Auer
Journal:  Acta Derm Venereol       Date:  2021-08-31       Impact factor: 3.875

Review 4.  Onychomycosis in Patients with Diabetes Mellitus in Africa: A Global Scoping Review, 2000-2021.

Authors:  Bassey E Ekeng; Winnie Kibone; Asa E Itam-Eyo; Felix Bongomin
Journal:  Mycopathologia       Date:  2022-09-03       Impact factor: 3.785

5.  Impact of direct-to-consumer drug advertising during the Super Bowl on drug utilization.

Authors:  Matthew P Gray; Alvaro San-Juan-Rodriguez; Nemin Chen; Chester B Good; Inmaculada Hernandez
Journal:  Res Social Adm Pharm       Date:  2019-12-09

6.  An Open Study to Evaluate Effectiveness and Tolerability of a Nail Oil Composed of Vitamin E and Essential Oils in Mild to Moderate Distal Subungual Onychomycosis.

Authors:  Aurora Alessandrini; Michela Starace; Francesca Bruni; Bianca Maria Piraccini
Journal:  Skin Appendage Disord       Date:  2019-10-25

7.  Computationally guided high-throughput design of self-assembling drug nanoparticles.

Authors:  Daniel Reker; Yulia Rybakova; Ameya R Kirtane; Ruonan Cao; Jee Won Yang; Natsuda Navamajiti; Apolonia Gardner; Rosanna M Zhang; Tina Esfandiary; Johanna L'Heureux; Thomas von Erlach; Elena M Smekalova; Dominique Leboeuf; Kaitlyn Hess; Aaron Lopes; Jaimie Rogner; Joy Collins; Siddartha M Tamang; Keiko Ishida; Paul Chamberlain; DongSoo Yun; Abigail Lytton-Jean; Christian K Soule; Jaime H Cheah; Alison M Hayward; Robert Langer; Giovanni Traverso
Journal:  Nat Nanotechnol       Date:  2021-03-25       Impact factor: 40.523

8.  Distinctions in the Management, Patient Impact, and Clinical Profiles of Pachyonychia Congenita Subtypes.

Authors:  Albert G Wu; Shari R Lipner
Journal:  Skin Appendage Disord       Date:  2021-02-05

9.  Molecular Epidemiology and Antifungal Susceptibility of Trichophyton Isolates in Greece: Emergence of Terbinafine-Resistant Trichophytonmentagrophytes Type VIII Locally and Globally.

Authors:  Maria Siopi; Ioanna Efstathiou; Konstantinos Theodoropoulos; Spyros Pournaras; Joseph Meletiadis
Journal:  J Fungi (Basel)       Date:  2021-05-27

10.  Topical and device-based treatments for fungal infections of the toenails.

Authors:  Kelly Foley; Aditya K Gupta; Sarah Versteeg; Rachel Mays; Elmer Villanueva; Denny John
Journal:  Cochrane Database Syst Rev       Date:  2020-01-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.